| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $302K | +78.8% |
| Cost of Revenue | $61K | +67.7% |
| Gross Profit | $240K | +81.8% |
| R&D Expense | $1.1M | -9.0% |
| SG&A Expense | $4.4M | +4.0% |
| Operating Income | -$8.4M | -8.2% |
| Interest Expense | -$8K | -158.1% |
| Pre-tax Income | -$8.2M | -8.0% |
| Net Income | -$8.2M | -8.1% |
| EPS (Basic) | -$0.50 | +39.8% |
| EPS (Diluted) | -$0.50 | +39.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $655K | +14.0% |
| Short-term Investments | $3.1M | +5.6% |
| Accounts Receivable | $82K | +525.4% |
| Inventory | $131K | -24.7% |
| Current Assets | $4.3M | +8.5% |
| Total Assets | $4.6M | +9.8% |
| Current Liabilities | $887K | +62.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | -25.7% |
| Investing Cash Flow | -$132K | +77.1% |
| Financing Cash Flow | $5.2M | +14.5% |
| $887K |
| +62.3% |
| Stockholders' Equity | $3.7M | +2.0% |